The disclosed derivatives of mycophenolic acid are therapeutic agents advantageous in the treatment of disease states indicated for mycophenolic acid and/or mycophenolate mofetil and other immunosuppressant agents.
披露的甲氧苯酸衍
生物是治疗用药,在治疗需要甲氧苯酸和/或甲氧苯酸酯酰基等
免疫抑制剂的疾病状态中具有优势。